Health officials traced the nation’s yellow fever outbreak to an individual who contracted the mosquito-borne illness Aug. 21. Since then, the outbreak has caused 35 suspected cases.
“This outbreak is of concern since the population of Ethiopia is highly susceptible to yellow fever due to absence of recent exposure and lack of large-scale immunization,” the WHO said in a Nov. 5 report cited by Reuters.
All of the confirmed yellow fever cases occurred in the country’s Offa Woreda district. Ethiopia launched a massive vaccination campaign in mid-October, which reached about 31,000 people. There have been no new confirmed cases in the area since the vaccination effort.
However, the WHO indicated there is a potential risk for the disease to further spread due to conflict within the region. Ethiopia plans to implement the yellow fever vaccine as part of a routine immunization regimen for all residents in 2020.
More articles on clinical leadership and infection control:
How Lucile Packard’s revamped donor matching processes for heart patients
Olympus plans for $85M loss linked to DOJ’s duodenoscope investigation
71% of hospitals did not improve clinical work environments over a decade, study finds
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
